Efficacy and Safety of Ephedra and Ephedrine for Weight Loss and Athletic Performance

[1]  S. Kimmel.  The relative safety of ephedra compared with other herbal products. , 2003, Annals of internal medicine.

[2]  M. Shlipak,et al.  The Relative Safety of Ephedra Compared with Other Herbal Products , 2003, Annals of Internal Medicine.

[3]  C. Viscoli,et al.  Use of Ephedra-containing products and risk for hemorrhagic stroke , 2003, Neurology.

[4]  C. Boozer,et al.  Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial , 2002, International Journal of Obesity.

[5]  N. Guvener,et al.  Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control. , 2001, Diabetes care.

[6]  E. Muls,et al.  The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study , 2001, International Journal of Obesity.

[7]  A. Wirth,et al.  Long-term weight loss with sibutramine: a randomized controlled trial. , 2001, JAMA.

[8]  I. Jacobs,et al.  Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. , 2001, Medicine and science in sports and exercise.

[9]  Smith Ig,et al.  Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. , 2001, The Journal of family practice.

[10]  S. Heymsfield,et al.  An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial , 2001, International Journal of Obesity.

[11]  M. Goulder,et al.  Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. , 2001, The Journal of family practice.

[12]  N. Benowitz,et al.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. , 2001, The New England journal of medicine.

[13]  A. Rissanen,et al.  Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns , 2000, International Journal of Obesity.

[14]  D. Molnár,et al.  Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents , 2000, International Journal of Obesity.

[15]  A. Ballinger.  Orlistat in the treatment of obesity , 2000, Expert opinion on pharmacotherapy.

[16]  T. McLellan,et al.  Reducing the dose of combined caffeine and ephedrine preserves the ergogenic effect. , 2000, Aviation, space, and environmental medicine.

[17]  D. Kalman,et al.  Effects of a weight-loss aid in healthy overweight adults: double-blind, placebo-controlled clinical trial , 2000 .

[18]  E. Stokic,et al.  Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia. , 1999, Medicinski pregled.

[19]  T. McLellan,et al.  Thermal regulation in the heat during exercise after caffeine and ephedrine ingestion. , 1999, Aviation, space, and environmental medicine.

[20]  K. Fujioka,et al.  Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. , 1999, The American journal of clinical nutrition.

[21]  I. Jacobs,et al.  Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test. , 1999, Aviation, space, and environmental medicine.

[22]  R. Morton.  Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise , 1999, European Journal of Applied Physiology and Occupational Physiology.

[23]  D. Cook,et al.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.

[24]  L. V. Van Gaal,et al.  Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study , 1998, European Journal of Clinical Pharmacology.

[25]  Ira Jacobs,et al.  Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise , 1998, European Journal of Applied Physiology and Occupational Physiology.

[26]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[27]  S. Toubro,et al.  Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate dietv fixed energy intake , 1997, BMJ.

[28]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[29]  G. Bray.  Evaluation of drugs for treating obesity. , 1995, Obesity research.

[30]  C S Berkey,et al.  A random-effects regression model for meta-analysis. , 1995, Statistics in medicine.

[31]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[32]  A. Astrup,et al.  The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[33]  L. Breum,et al.  Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[34]  A. Dulloo,et al.  Ephedrine in the treatment of obesity. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[35]  S. Toubro,et al.  The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. , 1992, Metabolism: clinical and experimental.

[36]  S. Toubro,et al.  [The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet. A randomized, placebo-controlled, double-blind trial]. , 1992, Ugeskrift for laeger.

[37]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[38]  N. Oksbjerg,et al.  [Aerobic training increases the effect of ephedrine on energy expenditure]. , 1986, Ugeskrift for laeger.

[39]  R. Pasquali,et al.  A controlled trial using ephedrine in the treatment of obesity. , 1985, International journal of obesity.

[40]  F. Quaade,et al.  Ephedrine as an anorectic: the story of the 'Elsinore pill'. , 1981, International journal of obesity.

[41]  B. Thorsteinsson,et al.  [Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets]. , 1980, Ugeskrift for laeger.

[42]  P. Danø,et al.  [Elsinore tablets and ephedrine as slimming agents]. , 1980, Ugeskrift for laeger.

[43]  The effects of ephedrine on the physiological and psychological responses to submaximal and maximal exercise in man. , 1977, Medicine and science in sports.

[44]  L. J. Duncan,et al.  Comparison of continuous and intermittent anorectic therapy in obesity. , 1968, British medical journal.